Cholangiocarcinoma risk factors and the potential role of aspirin
Hepatology
.
2016 Sep;64(3):708-10.
doi: 10.1002/hep.28613.
Epub 2016 May 28.
Authors
Fabio Bagante
1
2
,
T Clark Gamblin
3
,
Timothy M Pawlik
1
Affiliations
1
Division of Surgical Oncology, Department of Surgery, Johns Hopkins Hospital, Baltimore, MD.
2
Department of Surgery, University of Verona, Verona, Italy.
3
Department of Surgery, Medical College of Wisconsin, Milwaukee, WI.
PMID:
27112798
DOI:
10.1002/hep.28613
No abstract available
Publication types
Editorial
Comment
MeSH terms
Aspirin*
Bile Duct Neoplasms
Bile Ducts, Intrahepatic
Cholangiocarcinoma*
Humans
Risk Factors
Substances
Aspirin